Enable ME, L.L.C.

Enable ME, L.L.C., a foreign-owned, for-profit medical equipment distributor headquartered in Tampa, Florida, supplies specialized rehabilitation and mobility devices to the Department of Veterans Affairs and other federal healthcare systems as a prime contractor (100% of recent awards). The company holds a General Services Administration Medical Equipment and Supplies Schedule contract (FSS-65-II-F) valued at $1.49 million running through June 30, 2030, and competes predominantly in the full-and-open market without set-aside designations, though a minority of awards carry total small business set-aside designations.

Enable ME's customer concentration is overwhelmingly concentrated within the VA system across multiple Veterans Integrated Service Networks. The top five VISNs by award count account for 74% of all awards, with VISN 8 (Tampa/central Florida) dominating the portfolio at 314 awards and $4.1 million combined potential value. By potential value, VISN 12 anchors the portfolio with $11.2 million across nine awards, followed by VISN 8 at $4.1 million across 314 awards—a divergence that signals larger individual task orders from VISN 12 against a high-volume, lower-dollar transactional pattern from VISN 8. The vendor has served 25 distinct federal customer agencies; the VA accounts for approximately 84% of combined potential value. Enable ME has received single awards from the NIH Clinical Center and the U.S. Army Training and Doctrine Command (TRADOC), including an $85.5 thousand TRADOC purchase order for ophthalmology chairs at Brooke Army Medical Center.

Enable ME's recent work centers on motorized exercise and rehabilitation equipment—MOTOMED units in variants including MUVI (simultaneous leg and arm trainers), LOOP, and VIVA systems; ophthalmology patient examination chairs under the VELA product line (VELA Basic Plus, VELA Move, VELA Move+, VELA Thorax); prosthetics and electrical stimulation devices; wheelchairs; and assistive technologies. Representative recent awards include a $105.7 thousand May 2025 delivery order from VISN 9 for 24 VELA ophthalmology chairs, a $85.5 thousand September 2022 total small business set-aside purchase order from TRADOC for VELA Basic ophthalmology chairs, and a $60.7 thousand March 2026 delivery order from VISN 9 for VELA Basic Plus ophthalmology chairs. The company operates as a distributor of European-manufactured medical devices rather than a manufacturer; source descriptions identify it as a distributor of MOTOMED, VELA, HASOMED, and RECK-brand rehabilitation systems.

Activity in the award portfolio has grown from 21 awards in 2022 to a peak of 37 awards in 2024, declining to 21 in 2025 and 7 recorded in 2026 year-to-date. Five awards with ultimate completion dates in the next twenty-four months carry combined potential value of $151 thousand, posing minimal recompete exposure. Enable ME holds one major parent vehicle: the GSA Medical Equipment and Supplies Schedule (FSS-65-II-A), under which 405 task orders worth $5.2 million in combined potential value have been issued across the VA networks. The vendor operates without identified major subcontractors and performs all work directly as a prime contractor. The company maintains established relationships with multiple VA regional networks, having supplied specialized medical equipment to the VA healthcare system since at least 2006.